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Abstract
Human trophoblast expresses two fusogenic retroviral envelope proteins, the widely
studied syncytin 1, encoded by HERV-W and the recently characterized syncytin 2
encoded by HERV-FRD. Here we studied syncytin 2 in normal and Trisomy 21-
affected placenta associated with abnormal trophoblast differentiation. Syncytin 2
immunolocalization was restricted throughout normal pregnancy to some villous
cytotrophoblastic cells (CT). During the second trimester of pregnancy, syncytin 2
was immunolocalized in some cuboidal CT in T21 placentas, whereas in normal
placentas it was observed in flat CT, extending into their cytoplasmic processes. In
vitro CT isolated from normal placenta fuse and differentiate into syncytiotrophoblast;
syncytin 2 transcript levels decreased significantly with syncytiotrophoblast
formation. In contrast, CT isolated from T21-affected placentas fused and
differentiated poorly and no variation in syncytin 2 transcript levels was observed
with time in culture. Syncytin 2 expression illustrates the abnormal trophoblast
differentiation observed in placenta of fetal T21- affected pregnancies.
Background
Human endogenous retroviruses (HERV) comprise approximately 8% of the human
genome [1, 2]. Most of the identified elements are defective due to mutations and/or
deletions within their genes, but some elements have conserved intact open reading
frames. A systematic search for non-defective endogenous retrovirus envelope protein
genes has led to the identification of 16 genes [3]. Among them, two can induce cell-
cell fusion when expressed in different cells and are highly and specifically expressed
in the human placenta [4-6]. The products of these two genes are glycoproteins named
HERV-W Env glycoprotein (syncytin 1) and HERV-FRD Env glycoprotein (syncytin
2).
In the human placenta, the trophoblast differentiates along two major pathways both
critical for normal placental function [7]. In the extravillous trophoblast invasive
pathway, the cytotrophoblastic cells of the anchoring villi in contact with the uterus
wall proliferate, detach from the basement membrane and aggregate into multilayered
columns of non-polarized cells that invade the uterus wall (Fig.1). These cells, which
compose the extravillous cytotrophoblast (ECT), invade the endometrium, the first
third of the myometrium and the associated spiral arterioles. In the villous trophoblast
pathway, the cytotrophoblastic cells of the floating villi proliferate, differentiate and
fuse to form a syncytiotrophoblast (ST) that covers the entire surface of the villi
(Fig.1). The syncytiotrophoblast layer plays a major role throughout pregnancy, since
it is the site of numerous placental functions, including ion and nutrient exchange and
the synthesis of steroid and peptide hormones required for fetal growth and
development. This multinucleated syncytiotrophoblast is regenerated along pregnancy
by a continuous turnover process including proliferation of underlaying mononuclear
cytotrophoblasts (CT), fusion of these cytotrophoblasts into syncytiotrophoblast and
progression toward apoptosis.
In vitro isolated mononuclear cytotrophoblasts aggregate and fuse together to form a
non proliferative, multinucleated syncytiotrophoblast which secretes human chorionic
gonadotropin (hCG) and human placental lactogen (hPL), specific to pregnancy [8, 9].
Trisomy of chromosome 21 (T21), which causes the phenotype known as Down
syndrome, is the major known genetic cause of mental retardation and is found in
around 1:800 live births. Little is known about placental development in this
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aneuploid condition. However, a defect in syncytiotrophoblast formation in T21-
affected placentas is observed. Cultured cytotrophoblasts, isolated from T21-affected
placentas, aggregate but fuse poorly or belatedly [10-13].
Trophoblast fusion and differentiation directly involves different molecular actors
[14]. Among them, the HERV-W envelope glycoprotein named syncytin 1 is
expressed in all trophoblastic cells [15, 16] and directly involved in human
trophoblast fusion and differentiation [17]. HERV-FRD Env glycoprotein (or syncytin
2) has been more recently shown to be expressed in the human placenta [1, 4, 18].
The aim of this work was therefore to study in situ and in vitro the expression and
localization of syncytin 2 in human placenta at different stages of gestation, in normal
and T21-affected pregnancies.
Results
Syncytin 2 is immunolocalized in cytotrophoblastic cells throughout normal
pregnancy.
Figure 2 shows the syncytin 2 immunolocalization in chorionic villi throughout
normal pregnancy. In first trimester placenta (Fig.2 A-B), syncytin 2 was only
detected at the level of the cytotrophoblastic cells, which form a continuous single
layer of cuboidal cells beneath the syncytiotrophoblast. Immunostaining was observed
only in the cytoplasm of some cytotrophoblastic cells and never observed in the
syncytiotrophoblast and in the mesenchymal core of the villi (Fig.2 A-B). In second
trimester placenta (Fig.2 C-D), syncytin 2 immunostaining was present: 1/ in the
cytoplasm of cytotrophoblastic cells; 2/ in their thin elongated cytoplasmic processes
coming into contact with the syncytiotrophoblast and covering the villus basal lamina.
At term (Fig.2 E-F), immunostaining was detected at low magnification in a fraction
of the flat cytotrophoblastic cells and extended into their thin cytoplasmic processes.
Higher magnification showed the continuity of syncytin 2 immunostaining between
the cytoplasm surrounding the nuclei and that of the thin elongated cytoplasmic
processes.
Syncytin 2 immunostaining of cytotrophoblastic cells differs between T21 and
gestational age-matched control placentas.
A striking difference was observed between T21 second trimester placentas (18-19
weeks of gestation) and age-matched controls (Fig.3). Indeed, as previously
described, an increase in the thickness of the trophoblastic layer was observed in T21-
placenta. As shown in figure 4, syncytin 2 was immunolocalized in some cuboidal
cytotrophoblastic cells beneath the syncytiotrophoblast in T21 placentas (Fig.4 C-D).
In gestational age-matched controls, syncytin 2 was observed in some flat
cytotrophoblastic cells and extended into their thin elongated cytoplasmic processes
(Fig.4 A-B), as already noted above.
With time in culture Syncytin 2 transcript levels decrease in normal but not in
T21 cells.
Cytotrophoblastic cells isolated from the chorionic villi of second trimester normal
placentas adhere to plastic dishes, aggregate and fuse together to form a
syncytiotrophoblast within 48 to 72 hours (Fig.5 upper panel). Syncytin 2 positive
immunostaining was only observed in some cytotrophoblastic cells forming
aggregates; the staining was more intense at the sites of contact between these
syncytin 2-positive, aggregated cells (data not shown). No immunostaining was
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observed in multinucleated syncytiotrophoblast after 48 or 72 hours of culture.
Cytotrophoblastic cells isolated from T21-affected placentas adhered to the plastic
dishes, aggregated, but did not fuse or fused only after a delay and poorly
differentiated into syncytiotrophoblast (Fig.5 T21). This was not associated with any
significant increase in hCG secretion during the 72 hours of culture (Fig.5 bottom
panel). In these T21 trophoblastic cells, syncytin 2 transcript levels did not vary
during the 72 hours of culture (Fig.5 bottom panel). In contrast, in trophoblastic cells
isolated from age-matched control placentas, the in vitro formation of
syncytiotrophoblast was associated with a drastic increase in hCG secretion and
syncytin 2 transcript levels decreased significantly (p<0.02) between 24 and 72 hours
of culture (Fig.5).
Discussion
The role of endogenous retroviruses in placental morphogenesis and trophoblast
differentiation was hypothesized 10 years ago [19]. More recent studies point to the
presence of HERV-R (ERV 3), HERV-FRD, HERV-W, HERV-F, HERV-K and
HERV-T in human placenta, coding for intact retroviral Env proteins [3]. However
the role of theses retroviral envelope proteins is still poorly understood.
A role for the ERV-3 envelope protein (produced by the single-copy human
endogenous retrovirus ERV-3) have been suggested in trophoblast proliferation and
differentiation [20, 21]. However, the physiological knockout of the ERV-3 envelope
(lacking both the fusion peptide and the immunosuppressive domain) in 1% of the
Caucasian population [22] suggests that no essential function in placentation is
associated with the expression of the ERV-3 envelope protein.
HERV-W envelope protein, syncytin 1, is directly involved in villous trophoblast
fusion and differentiation [17]. The syncytin 1 is expressed in all trophoblastic cells,
villous and extravillous trophoblast, independently of their differentiation stage [15,
16].
In this study, we show that throughout pregnancy, HERV-FRD envelope protein,
syncytin 2 is detected in some villous cytotrophoblastic cell and therefore this
localization differs from syncytin 1 localization. All along pregnancy, the
syncytiotrophoblast regenerates from the fusion of the underlying cytotrophoblasts.
This process includes the continuous trophoblast turnover including proliferation of
cytotrophoblast progenitors, the withdrawal of cytotrophoblasts from the cell cycle to
G0, the recruitment of these post-mitotic cells to syncytiotrophoblast after membrane
fusion and progression of syncytiotrophoblast towards apoptosis. Therefore the
expression of syncytin 2 in some cytotrophoblastic cells suggest that it is expressed
when the cytotrophoblastic cell is engaged in the fusion stage. As illustrated in second
trimester placenta cytotrophoblastic cells are immunostained for syncytin 2 more
frequently at the level of the cell membrane and this staining occurs at the sites of
contact with the syncytiotrophoblast. Localization at this interface is precisely that
expected for a protein directly involved in the fusion of the mononuclear
cytotrophoblastic cells into the syncytiotrophoblast.
In addition, the syncytin 2 immunolabeling reflects the structural changes of the
cytotrophoblastic layer during pregnancy. Indeed, as recently demonstrated, the
cytotrophoblastic cell layer becomes thinner: the cuboidal cells are transformed to flat
cells with many cellular processes that together with those of the adjacent
syncytiotrophoblast eventually cover the basal lamina in a complex network of
interdigitations [23].
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In T21-affected placentas, localization of the labeled syncytin 2 differs notably from
that in gestational age-matched control placentas. Syncytin 2 is mainly located in the
cytoplasm of cuboidal cytotrophoblastic cells. This observation highlights in situ the
delay in the fusion process of T21 trophoblastic cells and the delay in the maturation
of the chorionic villi from T21-affected placentas [24, 25] (Fig.3).
In addition the transcript levels of syncytin 2 decreased significantly during in vitro
differentiation of normal cytotrophoblastic cells into syncytiotrophoblast. In contrast
in isolated T21 cytotrophoblastic cells, which did not fuse transcript levels of syncytin
2 did not vary with time in culture. Interestingly, we recently demonstrated that the in
vitro defect of syncytiotrophoblast formation in T21 is reversible when
cytotrophoblastic cells are treated with biosynthetic human chorionic gonadotropin.
These results point to a major role of abnormal hCG and its receptor in T21 placental
defect [26].
Envelope glycoprotein of HERV-W (syncytin 1) [17] interacts with its identified
receptor RDR, also known as the neutral aminoacid transporter SLC1A5/ASCT2 [5,
27]. Syncytin 2 entered the primate genome earlier than syncytin 1, namely before the
split between New World and Old World Monkeys (i.e > 40 Myrs ago). It also differs
in its receptor, as demonstrated by ex vivo cell-cell fusion assays using different cell
types [4]. The identification of this receptor and the direct role of syncytin 2 of in
human syncytiotrophoblast formation need to be investigated.
Recently, other retroviral envelope proteins have been identified in placenta from
other species. In mouse placenta two related env genes (syncytin A and syncytin B)
were characterized [28] and it was demonstrated that the endogenous Jaagsiekte sheep
retrovirus envelope regulates trophectoderm growth and differentiation in
perimplantation ovine conceptus [29]. The role of these retroviral envelope proteins in
fetoplacental development is still poorly known but their pleiotropic functions,
including immunosuppressive activity argue for a critical role [1, 30, 31].
Conclusions
In summary data presented here show that the highly fusogenic retroviral FRD
envelop protein, syncytin 2, is expressed in human placenta throughout pregnancy in
some cytotrophoblastic cells, which might be in the fusion stage. Syncytin 2
expression highlights the abnormal trophoblast differentiation observed in placenta of
fetal T21- affected pregnancies.
Methods
Placenta collection
First trimester placentas were obtained from legal induced abortions (8-12 weeks of
gestation). Term placentas were obtained after elective cesarean section from healthy
mothers near term with uncomplicated pregnancies. Samples of second trimester
placental tissues were collected at the time of termination of pregnancy at 12-25
weeks of gestation (in weeks of amenorrhea) in T21-affected pregnancies (n=5) and
gestational age-matched control cases (n=5) as previously described [10]. Fetal Down
syndrome was diagnosed by karyotyping of amniotic fluid cells, chorionic villi or
fetal blood cells. Termination of pregnancy was performed in control cases affected
by severe bilateral or low obstructive uropathy or major cardiac abnormalities. The
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karyotype of placental cells was checked in all cases (free trisomy 21 or normal). The
use of these biological samples was approved by our local ethical committee.
Immunohistochemistry
Placental samples were fixed in 4% formalin for 4-12h at room temperature and then
embedded in paraffin. Briefly, paraffin sections were dewaxed in xylene and
rehydrated in ethanol/water. Some sections were classically stained with H&E.
Immunostaining was performed with an universal streptavidin-peroxidase
immunostaining kit (Dako LSAB, Glostrup, Danemark) using a syncytin 2
monoclonal antibody [18]. All controls, performed with a mouse isotypic IgG1 at the
same concentration as the primary antibody were negative.
Cell culture
For in vitro culture villous cytotrophoblastic cells were isolated from second trimester
placentas (gestational age-matched controls and T21-affected placentas). 90%-95% of
the cells isolated from the normal or T21 placentas were cytokeratin 7-positive. Cells
plated in triplicate were cultured for 3 days. Trophoblastic fusion was monitored by
desmoplakin immunostaining and nuclei counting as previously described [14].
Quantification of specific transcripts by real- time RT-PCR
Total RNA was extracted from villous trophoblastic cells cultured for 24h and 72h
using QIAGEN RNeasy mini kit. cDNA synthesis and PCR amplification were
performed as described previously [10]. All PCR reactions were performed using an
ABI Prism 7700 Sequence Detection System and the SYBER Green PCR Core
Reagents kit (Perkin-Elmer). We used the following primers: FRD (+) 5’-GCCTGC A
AATAGTCTTCTTT-3’ and FRD (-) 5’-ATAGGGGCTATTCCCATTAG-3’. RNA
from the RPLP0 gene encoding the human acidic ribosomal phosphoprotein-P0 was
used as an internal control and each sample was normalized to RPLP0 transcript
content. The RPLP0 primers used for amplification were: (+) 5’-GGCGACCTGGAA
GTCCAAT-3’ and (-) 5’-CCATCAGCACCA CAGCCTTC-3’.
Hormonal assay
The hCG concentration was determined in culture medium at 24h and 72h of culture,
using an enzyme.
Competing interests
The author (s) declare that they have no competing interests.
Authors' contributions
AM performed most of the experimental work and wrote the manuscript. JLF carried
out the molecular studies in trophoblastic cells in culture, SB participated in
immunostaining, KH participated in immunocytochemistry, PG participated in the
isolation of trophoblastic cells, VT participated in placental collection, TH and DEB
conceived of the study and participated in its design and coordination and helped to
draft the manuscript.
H
AL author m
anuscript    inserm
-00221395, version 1
- 7 -
Acknowledgements
The authors wish to thank Prof. Foidart (Université de Lièges, Belgium) and the staff
of the Obstetrics Department of the Cochin, Saint Vincent de Paul, Broussais,
Beaujon and Robert Debré Hospitals (Paris, France), for assistance with specimen
collections, as well as Patrick Saunier and the Translational Research Laboratory
(Institut Gustave-Roussy, 94805 Villejuif) for expertise in RT-PCR analysis, Jean
Guibourdenche for expertise in hCG assay and Christian Lavialle for critical reading
of the manuscript.
This work was supported by la Caisse d'Assurance Maladie des Professions Libérales
Province and la CANAM.
References
1. de Parseval N, Heidmann T: Human endogenous retroviruses: from
infectious elements to human genes. Cytogenet Genome Res 2005, 110:318-
332.
2. Lander ES, Linton LM, Birren B, Nusbaum C, Zody MC, Baldwin J, Devon K,
Dewar K, Doyle M, FitzHugh W, et al: Initial sequencing and analysis of the
human genome. Nature 2001, 409:860-921.
3. de Parseval N, Lazar V, Casella JF, Benit L, Heidmann T: Survey of human
genes of retroviral origin: identification and transcriptome of the genes
with coding capacity for complete envelope proteins. J Virol 2003, 77:10414-
10422.
4. Blaise S, de Parseval N, Benit L, Heidmann T: Genomewide screening for
fusogenic human endogenous retrovirus envelopes identifies syncytin 2, a
gene conserved on primate evolution. Proc Natl Acad Sci U S A 2003,
100:13013-13018.
5. Blond J-L, Lavillette D, Cheynet V, Bouton O, Oriol G, Chapel-Fernandes S,
Mandrand B, Mallet F, Cosset FL: An envelope glycoprotein of the human
endogenous retrovirus HERV-W is expressed in the human placenta and
fuses cells expressing the type D mammalian retrovirus receptor. J Virol
2000, 74:3321-3329.
6. Mi S, Lee X, Li X, Veldman GM, Finnerty H, Racie L, LaVallie E, Tang XY,
Edouard P, Howes S, et al: Syncytin is a captive retroviral envelope protein
involved in human placental morphogenesis. Nature 2000, 403:785-789.
7. Bernischke K, Kaufmann P: Pathology of the human placenta. New-York; 2000.
8. Alsat E, Mirlesse V, Fondacci C, Dodeur M, Evain-Brion D: Parathyroid
hormone increases epidermal growth factor receptors in cultured human
trophoblastic cells from early and term placenta. J Clin Endocrinol Metab
1991, 73:288-295.
9. Kliman HJ, Nestler JE, Sermasi E, Sanger JM, Strauss JF: Purification,
characterization, and in vitro differentiation of cytotrophoblasts from
human term placentae. Endocrinology 1986, 118:1567-1582.
10. Frendo J-L, Vidaud M, Guibourdenche J, Luton D, Muller F, Bellet D,
Giovagrandi Y, Tarrade A, Porquet D, Blot P, Evain-Brion D: Defect of villous
H
AL author m
anuscript    inserm
-00221395, version 1
- 8 -
cytotrophoblast differentiation into syncytiotrophoblast in Down's
syndrome. J Clin Endocrinol Metab 2000, 85:3700-3707.
11. Pidoux G, Guibourdenche J, Frendo J-L, Gerbaud P, Conti M, Luton D, Muller
F, Evain-Brion D: Impact of trisomy 21 on human trophoblast behaviour
and hormonal function. Placenta 2004, 25 Suppl A:S79-84.
12. Frendo J-L, Guibourdenche J, Pidoux G, Vidaud M, Luton D, Giovangrandi Y,
Porquet D, Muller F, Evain-Brion D: Trophoblast production of a weakly
bioactive human chorionic gonadotropin in trisomy 21-affected pregnancy.
J Clin Endocrinol Metab 2004, 89:727-732.
13. Pidoux G, Gerbaud P, Marpeau O, Guibourdenche J, Ferreira F, Badet J, Evain-
Brion D, Frendo J-L: Human placental development is impaired by
abnormal hCG signaling in trisomy 21 pregnancies. Endocrinology 2007.
14. Frendo J-L, Cronier L, Bertin G, Guibourdenche J, Vidaud M, Evain-Brion D,
Malassine A: Involvement of connexin 43 in human trophoblast cell fusion
and differentiation. J Cell Sci 2003, 116:3413-3421.
15. Malassine A, Handschuh K, Tsatsaris V, Gerbaud P, Cheynet V, Oriol G, Mallet
F, Evain-Brion D: Expression of HERV-W Env glycoprotein (syncytin) in
the extravillous trophoblast of first trimester human placenta. Placenta
2005, 26:556-562.
16. Muir A, Lever AM, Moffett A: Human endogenous retrovirus-W envelope
(syncytin) is expressed in both villous and extravillous trophoblast
populations. J Gen Virol 2006, 87:2067-2071.
17. Frendo J-L, Olivier D, Cheynet V, Blond JL, Bouton O, Vidaud M, Rabreau M,
Evain-Brion D, Mallet F: Direct involvement of HERV-W Env glycoprotein
in human trophoblast cell fusion and differentiation. Mol Cell Biol 2003,
23:3566-3574.
18. Malassine A, Blaise S, Handschuh K, Lalucque H, Dupressoir A, Evain-Brion
D, Heidmann T: Expression of the Fusogenic HERV-FRD Env Glycoprotein
(Syncytin 2) in Human Placenta is Restricted to Villous Cytotrophoblastic
Cells. Placenta 2007, 28:185-191.
19. Harris JR: Placental endogenous retrovirus (ERV): structural, functional,
and evolutionary significance. Bioessays 1998, 20:307-316.
20. Lin L, Xu B, Rote NS: Expression of endogenous retrovirus ERV-3 induces
differentiation in BeWo, a choriocarcinoma model of human placental
trophoblast. Placenta 1999, 20:109-118.
21. Lin L, Xu B, Rote NS: The cellular mechanism by which the human
endogenous retrovirus ERV-3 env gene affects proliferation and
differentiation in a human placental trophoblast model, BeWo. Placenta
2000, 21:73-78.
22. de Parseval N, Heidmann T: Physiological knockout of the envelope gene of
the single-copy ERV-3 human endogenous retrovirus in a fraction of the
Caucasian population. J Virol 1998, 72:3442-3445.
23. Mori M, Ishikawa G, Luo SS, Mishima T, Goto T, Robinson JM, Matsubara S,
Takeshita T, Kataoka H, Takizawa T: The cytotrophoblast layer of human
chorionic villi becomes thinner but maintains its structural integrity during
gestation. Biol Reprod 2007, 76:164-172.
24. Oberweis D, Gillerot Y, Koulischer L, Hustin J, Philippe E: The placenta in
trisomy in the last trimester of pregnancy. J Gynecol Obstet Biol Reprod
(Paris) 1983, 12:345-349.
H
AL author m
anuscript    inserm
-00221395, version 1
- 9 -
25. Roberts L, Sebire NJ, Fowler D, Nicolaides KH: Histomorphological features
of chorionic villi at 10-14 weeks of gestation in trisomic and chromosomally
normal pregnancies. Placenta 2000, 21:678-683.
26. Pidoux G, Gerbaud P, Marpeau O, Guibourdenche J, Ferreira F, Badet J, Evain-
Brion D, Frendo J-L: Human placental development is impaired by
abnormal human chorionic gonadotropin signaling in trisomy 21
pregnancies. Endocrinology 2007, 148:5403-5413.
27. Cheynet V, Oriol G, Mallet F: Identification of the hASCT2-binding domain
of the Env ERVWE1/syncytin-1 fusogenic glycoprotein. Retrovirology 2006,
3:41.
28. Dupressoir A, Marceau G, Vernochet C, Benit L, Kanellopoulos C, Sapin V,
Heidmann T: Syncytin-A and syncytin-B, two fusogenic placenta-specific
murine envelope genes of retroviral origin conserved in Muridae. Proc Natl
Acad Sci U S A 2005, 102:725-730.
29. Dunlap KA, Palmarini M, Varela M, Burghardt RC, Hayashi K, Farmer JL,
Spencer TE: Endogenous retroviruses regulate periimplantation placental
growth and differentiation. Proc Natl Acad Sci U S A 2006, 103:14390-14395.
30. Prudhomme S, Bonnaud B, Mallet F: Endogenous retroviruses and animal
reproduction. Cytogenet Genome Res 2005, 110:353-364.
31. Gong R, Huang L, Shi J, Luo K, Qiu G, Feng H, Tien P, Xiao G: Syncytin-A
mediates the formation of syncytiotrophoblast involved in mouse placental
development. Cell Physiol Biochem 2007, 20:517-526.
H
AL author m
anuscript    inserm
-00221395, version 1
- 10 -
Figures
Figure 1
A. In humans, at 10-12 weeks of pregnancy, the chorionic floating villi are in contact
with the maternal blood in the maternal blood space (MBS). In these villi,
cytotrophoblastic cells (CT) differentiate by fusion to generate the
syncytiotrophoblast (ST). In the anchoring villi the cytotrophoblastic cells proliferate
and invade the decidua (DC). The extravillous cytotrophoblastic cells (ECT) invade
the lumen of uterine arteries (UA). FC: Fetal capillary; M: mesenchyme.
B. Evolution of human floating chorionic villi. The chorionic villi, in direct contact
with the maternal blood in the maternal blood space (MBS), consist of
cytotrophoblastic cells (CT) and syncytiotrophoblast (ST) surrounding a core of
mesenchymal cells including fetal capillaries (FC), fibroblasts (F) and Hofbauer cells
(HC). BL: basal lamina.
Figure 2
Immunohistochemical analysis of syncytin 2 (HERV-FRD Env) in human placenta.
Top panel. First trimester floating villi (8 weeks of pregnancy). A. Syncytin 2 was
detected in some cytotrophoblastic cells (CT). No immunostaining was observed in
the syncytiotrophoblast (ST) and in the mesenchymal core (MC). Scale bar= 10µm. B.
This large magnification allows to clearly establish the cytoplasmic localization of
syncytin 2 immunostaining in a pair of cytotrophoblastic cells. At this gestational age
the cytotrophoblast consists of a continuous single layer of cuboidal cells beneath the
syncytiotrophoblast. Scale bar= 10µm. Arrowhead: non labeled CT, arrow: positively
stained CT.
Middle panel. Second trimester placenta (16 weeks of pregnancy). C. Immunostaining
with anti-syncytin2 antibody shows positive reactivity in some cytotrophoblastic cells.
No syncytin 2 reactivity was detected in the extravillous trophoblast (ECT), in the
syncytiotrophoblast and in the mesenchymal core. Scale bar= 10µm. D. In this
floating villi, syncytin 2 immunostaining was observed in the cytoplasm of some
cytotrophoblastic cells (arrow), in their thin cytoplasmic processes (star) and at the
level of the trophoblastic basal lamina (double head arrow). Scale bar= 10µm.
Bottom panel. Term placenta floating villi. E. Syncytin 2 was detected in the
cytoplasm surrounding the nuclei of flat cytotrophoblastic cells and in their thin
elongated cytoplasmic processes. Staining was absent from some villi. Scale bar=
10µm. F. This large magnification allows to clearly establish the syncytin 2
immunostaining continuity within cytotrophoblasts between the cytoplasm
surrounding the nuclei and that of the thin cytoplasmic processes. Scale bar= 10µm.
Figure 3.
Second trimester chorionic villi of normal (19 weeks of amenorrhea: wa) and trisomy
21 (18 wa) placentae. In normal placenta, a large amount of cytotrophoblastic cells
(CT) have fused into a thin multinucleated syncytiotrophoblast (ST). In trisomy 21
placenta, many cuboidal cytotrophoblastic cells (CT) are still present beneath the
syncytiotrophoblast (ST) increasing the thickness of the trophoblastic layer. Scale
bar= 10µm.
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Figure 4
Immunohistochemical analysis of syncytin 2 (HERV-FRD Env) in age-matched
second trimester (19 weeks) normal (upper panel) and T21-affected placentas (lower
panel). Upper panel A. Immunostaining with anti-syncytin2 antibody showed positive
reactivity in a fraction of elongated cytotrophoblastic cells. Scale bar= 10µm. B. In
this large magnification, syncytin 2 immunostaining was observed in the cytoplasm of
cytotrophoblastic cells and in the thin cytoplasmic processes. Scale bar= 10µm.
Lower panel C. Syncytin 2 was detected in some cuboidal cytotrophoblastic cells.
Scale bar= 10µm. D. This high magnification shows the cytoplasmic localization of
syncytin 2 immunostaining in several cytotrophoblastic cells. Scale bar= 10µm.
Figure 5.
Morphological differentiation (upper panel), real-time RT-PCR analysis of syncytin 2
(HERV-FRD env) transcripts (lower left panel) and hCG secretion (lower rigth panel)
during in vitro culture of control and T21 trophoblastic cells. Cytotrophoblastic cells
were purified from three distinct age matched (second trimester) control and T21-
affected placentas and separately cultured. The cells were visualized under phase
contrast light microscopy (Scale bar= 10µm). At 72 h, normal cytotrophoblastic cells
had fused resulting in the formation of a large syncytium containing numerous nuclei.
In contrast, T21 cytotrophoblasts were still aggregated and had not fused. Total
mRNA were extracted after 24 and 72 h of culture. Data are expressed as the level of
syncytin 2 mRNA normalized to that of RPLP0 mRNA. HCG secretion into the
culture medium was measured at the indicated times, in normal (N) and T21-affected
cell cultures. Results are the means ± SEM of triplicate dishes from three different
cultures.
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